Cytisinicline for Vaping Cessation in Adults Using Nicotine E-Cigarettes

Less than a year after reporting on the successful use of cytisinicline for smoking cessation in a Phase 3 trial, Rigotti et al. have now shown the drug to be effective for vaping cessation among single-use ENDS users. If the FDA approves cytisinicline, it will be the first new tobacco cessation drug in 20 years. Read the full article via the JAMA Network website.

The associated files and links are available below.